| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/30/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Common Stock | 3k | $0.94 | $2.8k | | 11/30/2022 |
| 08/01/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 75k | $1.57 | $117.8k | | 08/01/2022 |
| 06/17/2022 | Crinetics Pharmaceuticals, Inc. | CRNX | Grant | Stock Option (right to buy) | 4.4k | $18.29 | $80k | | 06/17/2022 |
| 05/31/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Common Stock | 3k | $0.99 | $3k | | 05/31/2022 |
| 03/11/2022 | Crinetics Pharmaceuticals, Inc. | CRNX | Grant | Stock Option (right to buy) | 35k | $19.30 | $675.5k | | 03/11/2022 |
| 03/11/2022 | Crinetics Pharmaceuticals, Inc. | CRNX | Grant | Stock Option (right to buy) | 25k | $19.30 | $482.5k | | 03/11/2022 |
| 02/15/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 75k | $3.19 | $239.2k | | 02/15/2022 |
| 09/16/2021 | Magenta Therapeutics, Inc. | MGTA | Sale | Common Stock | 6.2k | $6.73 | $42k | | 09/16/2021 |
| 09/14/2021 | Magenta Therapeutics, Inc. | MGTA | Grant | Common Stock | 20k | $0.00 | $0 | | 09/14/2021 |
| 07/06/2021 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 200k | $9.41 | $1.9M | | 07/06/2021 |